Harmony Biosciences Holdings Inc [HRMY] stock prices are down -2.28% to $38.92 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The HRMY shares have gain 9.60% over the last week, with a monthly amount glided 25.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Harmony Biosciences Holdings Inc [NASDAQ: HRMY] stock has seen the most recent analyst activity on July 21, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $48. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $55 on February 11, 2025. H.C. Wainwright initiated its recommendation with a Buy and recommended $75 as its price target on December 17, 2024. In a note dated September 10, 2024, UBS initiated an Buy rating and provided a target price of $56 on this stock.
The stock price of Harmony Biosciences Holdings Inc [HRMY] has been fluctuating between $25.52 and $40.93 over the past year. Currently, Wall Street analysts expect the stock to reach $47.8 within the next 12 months. Harmony Biosciences Holdings Inc [NASDAQ: HRMY] shares were valued at $38.92 at the most recent close of the market. An investor can expect a potential return of 22.82% based on the average HRMY price forecast.
Analyzing the HRMY fundamentals
The Harmony Biosciences Holdings Inc [NASDAQ:HRMY] reported sales of 825.94M for trailing twelve months, representing a surge of 28.71%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.25 and Total Capital is 0.23. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.35 points at the first support level, and at 37.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 39.75, and for the 2nd resistance point, it is at 40.57.
Ratios To Look Out For
It’s worth pointing out that Harmony Biosciences Holdings Inc [NASDAQ:HRMY]’s Current Ratio is 3.75. On the other hand, the Quick Ratio is 3.72, and the Cash Ratio is 2.9. Considering the valuation of this stock, the price to sales ratio is 2.71, the price to book ratio is 2.68 and price to earnings (TTM) ratio is 12.26.
Transactions by insiders
Recent insider trading involved SANDIP KAPADIA, Officer, that happened on Dec 05 ’25 when 20000.0 shares were purchased. CHIEF FINANCIAL OFFICER, Kapadia Sandip completed a deal on Nov 21 ’25 to sell 3427.0 shares. Meanwhile, Officer SANDIP KAPADIA bought 3427.0 shares on Nov 21 ’25.
